SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-24-040846
Filing Date
2024-05-08
Accepted
2024-05-08 16:01:47
Documents
1
Group Members
STEPHEN L. GUSTIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea0205585-13dexplor_fresh.htm SC 13D 70422
  Complete submission text file 0001213900-24-040846.txt   72249
Mailing Address 2000 CENTRAL AVENUE SUITE 100 BOULDER CO 80301
Business Address 2000 CENTRAL AVENUE SUITE 100 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Subject) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-42755 | Film No.: 24925737
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 250 EAST 200 SOUTH, FLOOR 16 SALT LAKE CITY UT 84111
Business Address 250 EAST 200 SOUTH, FLOOR 16 SALT LAKE CITY UT 84111 (212) 220-4444
Exploration Capital, LLC (Filed by) CIK: 0002003514 (see all company filings)

IRS No.: 843905486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D